The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of www.DBS-STN.org. 

Browse by Topic:
Search:

Medtronic Recently Received FDA Approval of Updated Labeling for DBS for Parkinson’s Disease


Medtronic recently received FDA approval of updated labeling for DBS for Parkinson’s disease, supporting the growing evidence that Medtronic DBS Therapy, in addition to medication, is associated with benefits over time. These benefits include quality of life/motor function improvements, significantly reduced medication use, and long-term safety and effectiveness. Read more…



Article Archive

back